Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Armstrong

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Heart (British Cardiac Society)|March 12, 2008
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevationR D Lopes, K S Pieper, J R Horton, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS TrialJ H Alexander, H Yang, R C Becker, et al.
Circulation|October 12, 2000
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III TrialE J Topol, E M Ohman, P W Armstrong, et al.
European Heart Journal|February 27, 2004
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromesM T Roe, K W Mahaffey, R Kilaru, et al.
The American Journal of Cardiology|April 24, 1999
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Harrington, R H Tuttle, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examinationC V Leier, J B Young, T B Levine, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI PilotJ H Alexander, C K Dyke, H Yang, et al.
Lancet (London, England)|September 4, 1999
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, F Van De Werf, J Adgey, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Heart (British Cardiac Society)|March 12, 2008
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevationR D Lopes, K S Pieper, J R Horton, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS TrialJ H Alexander, H Yang, R C Becker, et al.
Circulation|October 12, 2000
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III TrialE J Topol, E M Ohman, P W Armstrong, et al.
European Heart Journal|February 27, 2004
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromesM T Roe, K W Mahaffey, R Kilaru, et al.
The American Journal of Cardiology|April 24, 1999
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Harrington, R H Tuttle, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examinationC V Leier, J B Young, T B Levine, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI PilotJ H Alexander, C K Dyke, H Yang, et al.
Lancet (London, England)|September 4, 1999
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, F Van De Werf, J Adgey, et al.
Pageof 29